ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Infectious Disease

Top Infectious Disease Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIO FIORILLI MD

Infectious Disease

15,474

$978K

467
354 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 52%

$63
Average prescription price

Avg: $401

ASIF ZIA MD, MPH

Infectious Disease

7,357

$728K

277
156 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 52%

$99
Average prescription price

Avg: $401

FREDERICK CRUICKSHANK M.D.

Infectious Disease

6,309

$3.02M

194
30 are 65+

20%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 52%

$478
Average prescription price

Avg: $401

PAUL KAMITSUKA MD

Infectious Disease

6,038

$943K

459
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 52%

$156
Average prescription price

Avg: $401

GARY COX M.D.

Infectious Disease

5,856

$2.49M

187
36 are 65+

37%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 52%

$425
Average prescription price

Avg: $401

RICHARD RUMLEY MD

Infectious Disease

5,822

$1.62M

260
97 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 52%

$277
Average prescription price

Avg: $401

EMMA CASTILLO MD

Infectious Disease

4,255

$398K

148
81 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 52%

$94
Average prescription price

Avg: $401

WILLIAM HARLEY M.D.

Infectious Disease

4,004

$2.9M

297
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 52%

$724
Average prescription price

Avg: $401

JAMES HORTON MD

Infectious Disease

3,938

$2.03M

155
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 52%

$515
Average prescription price

Avg: $401

DAVID WEINRIB MD

Infectious Disease

3,270

$1.99M

143
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 52%

$609
Average prescription price

Avg: $401

KELLY VOLLMER M.D.

Infectious Disease

2,917

$744K

275
80 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 52%

$255
Average prescription price

Avg: $401

PAUL COOK MD

Infectious Disease

2,509

$1.59M

94
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 52%

$634
Average prescription price

Avg: $401

MICHAEL BLOCKER M.D.

Infectious Disease

2,508

$476K

200
135 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 52%

$190
Average prescription price

Avg: $401

AIMEE WILKIN MD

Infectious Disease

2,414

$1.39M

172
14 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 52%

$578
Average prescription price

Avg: $401

CAMERON WOLFE MD

Infectious Disease

2,370

$1.43M

81
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 52%

$604
Average prescription price

Avg: $401

JEFFREY HATCHER M.D.

Infectious Disease

2,200

$1.22M

152
30 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 52%

$555
Average prescription price

Avg: $401

TEDRA CLAYTOR MD

Infectious Disease

2,169

$1.53M

114
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 52%

$704
Average prescription price

Avg: $401

CORNELIUS VAN DAM M.D.

Infectious Disease

2,161

$983K

187
68 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 52%

$455
Average prescription price

Avg: $401

JOHN CAMPBELL MD

Infectious Disease

2,035

$1.12M

129
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 52%

$551
Average prescription price

Avg: $401

ARTHUR LINK MD

Infectious Disease

1,761

$766K

140
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 52%

$435
Average prescription price

Avg: $401

CHARLES HICKS

Infectious Disease

1,746

$861K

72
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 52%

$493
Average prescription price

Avg: $401

LUIS BARROSO MD

Infectious Disease

1,588

$806K

88
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 52%

$507
Average prescription price

Avg: $401

DAVID MCCLAIN MD

Infectious Disease

1,576

$777K

128
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 52%

$493
Average prescription price

Avg: $401

TIMOTHY LANE M.D.

Infectious Disease

1,472

$443K

754
529 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 52%

$301
Average prescription price

Avg: $401

DAVID PRIEST M.D.

Infectious Disease

1,458

$673K

185
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 52%

$462
Average prescription price

Avg: $401

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank